Rapport Therapeutics (NASDAQ:RAPP) Is In A Strong Position To Grow Its Business

Simply Wall StDec 9, 2024 09:09 ET

Jefferies Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsDec 9, 2024 08:31 ET · Ratings

Rapport Therapeutics, Inc. (RAPP) Receives a Buy From Jefferies

TipRanksDec 9, 2024 08:26 ET · Ratings

We're Not Worried About Rapport Therapeutics' (NASDAQ:RAPP) Cash Burn

Yahoo FinanceDec 7, 2024 07:18 ET

Rapport Therapeutics Management to Meet With Truist

TipRanksDec 6, 2024 13:45 ET

Rapport Therapeutics Reports Correlation Between Seizure Biomarker, Clinical Seizures

MT NewswiresDec 6, 2024 12:36 ET